• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CMXHF:US

65.7500 USD 0.8400 1.26%

As of 20:10:00 ET on 09/16/2014.

Snapshot for CSL Ltd (CMXHF)

Open: 65.7500 Day's Range: 65.7500 - 65.7500 Volume: 165
Previous Close: 66.5900 52wk Range: 59.0600 - 69.1900 1-Yr Rtn: -

Stock Chart for CMXHF

No chart data available.
  • CMXHF:US 65.7500
  • 1D
  • 1M
  • 1Y
66.5900
Interactive CMXHF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CMXHF

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 21.0940
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) 3.1170
Est. PEG Ratio 1.6671
Market Cap (M USD) 31,286.17
Shares Outstanding (M) 475.84
30 Day Average Volume 60
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.73%
Cash Dividend (AUD) 0.6485
Dividend Ex-Date 09/08/2014
5 Year Dividend Growth 16.07%
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMXHF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CMXHF

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerMary SontropExec VP:Manufacturing
More Company Profile & Key Executives for CMXHF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil